Rune Labs Secures $12 Million in Strategic Funding Round

In a groundbreaking move towards revolutionizing neurology, San Francisco-based precision neurology software and data company, Rune Labs, has successfully raised a substantial $12 million in a strategic funding round, catapulting its total funding to an impressive $42 million.

The driving force behind this financial injection was Nexus NeuroTech Ventures, spearheading the round and joined by stalwart existing investors including Eclipse, DigiTx Partners, Moment Ventures, and TruVenturo GmbH. Notably, Jordi Parramon, PhD, luminary CEO, General Partner, and Co-Founder of Nexus NeuroTech Ventures, and former President of Medical Devices at Verily, is set to bring his extensive experience to the table by joining Rune Labs’ illustrious board of directors.

At the helm of this innovation voyage is Brian Pepin, the visionary CEO of Rune Labs.

The company stands as a trailblazing software and data analytics powerhouse, with a particular focus on precision neurology that not only supports care delivery but also propels therapy development into uncharted territories.

Rune Labs’ flagship offering, StrivePD, serves as a groundbreaking care delivery ecosystem specifically designed for Parkinson’s disease.

This ingenious platform empowers both patients and clinicians by providing seamless access to curated dashboards, consolidating a myriad of patient data sources.

Moreover, it acts as a bridge, connecting patients with clinical trials that could potentially redefine the landscape of Parkinson’s treatment.

The newly acquired funding is poised to propel Rune Labs into an accelerated phase of novel Parkinson’s technologies adoption.

With a strategic vision, the company aims to leverage these funds to further enhance its capabilities and make a significant impact on the understanding and treatment of Parkinson’s disease.

Brian Pepin, the driving force behind Rune Labs, shared his enthusiasm regarding the partnership with Nexus NeuroTech Ventures. Pepin noted, “With over 25 years of experience, Jordi brings deep knowledge in building businesses and products at the intersection of data and healthcare.

This strategic partnership with Nexus NeuroTech Ventures is in line with our use of modern AI tools to support patients, clinicians, and our pharma partners, and speaks to our ambition to have a deep impact on the way Parkinson’s is understood and treated.”

Rune Labs Funding is not just a financial milestone; it symbolizes a leap toward a future where precision neurology reshapes the narrative of patient care and therapy development.

As Rune Labs embarks on this transformative journey, the infusion of $12 million signals not only a validation of their pioneering efforts but also a testament to the collective belief in their potential to redefine the landscape of neurology.

ALSO READ: Parallel’s $6.125M Funding Fuels Teletherapy Evolution

Leave a Comment

Ravi Kishan Shines in ‘Maamla Legal Hai’: Netflix’s Hilarious Take on Courtroom Chaos Kamal Haasan: A Cinematic Maestro’s Journey Unveiled Hardik Pandya: All-Rounder Extraordinaire The Enchanting Journey of Rebecca Ferguson Chanda Kochhar: Banking Trailblazer